Fig. 3
From: The design of a Bayesian adaptive clinical trial of tranexamic acid in severely injured children
Summaries of expected sample sizes by injury group and arm for the null scenario (scenario 1 [no benefit or harm seen with TXA across injury groups]). The bars display the median and the lines display the 10th and 90th percentile of the expected sample sizes